Home
Ronald Harold Wilfred Cooper, CEO: enGene Therapeutics ENGN Buy · Filed 24/10/01
Trade details
- Type
- Insider buy
- Amount
- $57,000
- Shares · price
- 10,000 sh · $5.70 a share
- Held after
- 10,000 sh
- Trade date
- 24/09/27
- Filed
- 24/10/01
- Days to filing
- 4 days
First buy since 2023
- Insiders buying this week
- 3 insiders
enGene Therapeutics trades, last 26 weeks
What else happened in enGene Therapeutics around then
Filed or reported within 30 days of the trade day · 24/08/28~24/10/27Ronald Harold Wilfred Cooper's recent trades
- Ronald Harold Wilfred Cooper
SellAlbireo Pharma
SellAlbireo Pharma
ALBO
$46.3K
1,057 sh
$46.3K
Filed 23/01/23
Traded 23/01/23
- Ronald Harold Wilfred Cooper
SellAlbireo Pharma
SellAlbireo Pharma
ALBO
$18K
919 sh
$18K
Filed 23/01/09
Traded 22/10/24